Pages that link to "Q43806484"
Jump to navigation
Jump to search
The following pages link to Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study (Q43806484):
Displaying 50 items.
- Anticancer effects of the nitric oxide-modified saquinavir derivative saquinavir-NO against multidrug-resistant cancer cells (Q24628715) (← links)
- Drug efflux transporters and multidrug resistance in acute leukemia: therapeutic impact and novel approaches to mediation (Q26824355) (← links)
- Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities (Q26828930) (← links)
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance (Q26865927) (← links)
- The clinically relevant pharmacogenomic changes in acute myelogenous leukemia (Q27014790) (← links)
- Hematopoietic cell transplantation beyond first remission (Q28200716) (← links)
- Multidrug resistance in cancer: role of ATP-dependent transporters (Q28208049) (← links)
- Synthesis of a dual functional anti-MDR tumor agent PH II-7 with elucidations of anti-tumor effects and mechanisms (Q28481389) (← links)
- Targeting multidrug resistance in cancer (Q29616803) (← links)
- Tumour stem cells and drug resistance (Q29617742) (← links)
- Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421. (Q30444746) (← links)
- Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia (Q30497200) (← links)
- Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples? (Q33221958) (← links)
- ABC transporters and drug resistance in leukemia: was P-gp nothing but the first head of the Hydra? (Q33281867) (← links)
- Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML). (Q33319637) (← links)
- Southwestern Oncology Group pretreatment risk criteria as predictive or prognostic factors in acute myeloid leukemia (Q33598706) (← links)
- Mechanism Underlying the Reversal of Drug Resistance in P-Glycoprotein-Expressing Leukemia Cells by Pinoresinol and the Study of a Derivative (Q33600323) (← links)
- P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA (Q33934534) (← links)
- Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia (Q33949752) (← links)
- The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression. (Q33961526) (← links)
- Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature in acute myeloid leukaemia (Q33981864) (← links)
- Challenges in treating older patients with acute myeloid leukemia (Q33985549) (← links)
- New positron emission tomography tracer [(11)C]carvedilol reveals P-glycoprotein modulation kinetics (Q33987752) (← links)
- P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808 (Q34124919) (← links)
- P-glycoprotein in acute myeloid leukaemia: therapeutic implications of its association with both a multidrug-resistant and an apoptosis-resistant phenotype (Q34142289) (← links)
- Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia (Q34154708) (← links)
- Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia (Q34155343) (← links)
- Molecular pathways: regulation and therapeutic implications of multidrug resistance (Q34255292) (← links)
- The Role of ABC Transporters in Clinical Practice (Q34268081) (← links)
- P-glycoprotein: from genomics to mechanism. (Q34272173) (← links)
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999 (Q34360283) (← links)
- Incorporating FLT3 inhibitors into acute myeloid leukemia treatment regimens (Q34591403) (← links)
- Acute myeloid leukemia: treatment of adults under 60 years (Q34680933) (← links)
- Acute myeloid leukemia: treatment over 60. (Q34680938) (← links)
- Treatment of refractory and relapsed acute myelogenous leukemia (Q34734034) (← links)
- Older adults with acute myeloid leukemia (Q34774180) (← links)
- Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance (Q34774854) (← links)
- The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia (Q34962889) (← links)
- Considerations in the design and development of transport inhibitors as adjuncts to drug therapy (Q35048758) (← links)
- Overview of the clinical efficacy of investigational anticancer drugs (Q35067125) (← links)
- Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences (Q35177652) (← links)
- ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients (Q35193725) (← links)
- Strategies for reversing drug resistance (Q35567287) (← links)
- Management of acute myelogenous leukemia in the elderly (Q35599067) (← links)
- The therapy of relapsed acute leukaemia in adults (Q35610850) (← links)
- New agents in acute myeloid leukemia and other myeloid disorders (Q35639964) (← links)
- Analysis of the interaction of induction regimens with p-glycoprotein expression in patients with acute myeloid leukaemia: results from the MRC AML15 trial. (Q35664332) (← links)
- Reversal of MDR by verapamil analogues (Q35668684) (← links)
- P glycoprotein in human immunodeficiency virus type 1 infection and therapy (Q35718765) (← links)
- Changing picture of cellular drug resistance in human leukemia (Q35749778) (← links)